IP Library Granted Patent US 6,905,705
Granted Patent B2
US 6,905,705 · App. 10/824,988 · Granted Jun 14, 2005

Multipack for removing filled bags in a predetermined sequence

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,905,705
App. No.
10/824,988
Granted
Jun 14, 2005
Kind
B2
Abstract

This invention provides for, inter alia, a multipack comprising at least two different bags, wherein the bags are arranged in a predetermined sequence and are joined together in a single block. The inventive multipacks provide for, for example, a simplified method for the transdermal administration of therapeutic agents such as hormones to a patient in need thereof.

Claims (17)

1. A method for transdermal administration of hormones to a patient involving a multipack comprising at least two individual bags that are joined together to form a block, wherein

each individual bag comprises an inner area, which contains a transdermal therapy system (TTS),

each individual bag possesses an edge that encloses the inner area,

the individual bags are arranged in a predetermined sequence, and whereas within said block,

an edge section of a first bag lies almost over the edge section of a second adjacent bag, thereby superimposing the edge sections of the two adjacent bags,

the superimposed edge sections of the two adjacent bags are offset with respect to each other, and

the superimposed edge sections of the respectively adjacent bags are connected to one another,

wherein the sequence of said bags in said block corresponds to the predetermined sequence of removal, said method comprising of a first treatment phase and a second treatment phase, where in said first treatment phase at least one transdermal therapy system (TTS) containing at least one estrogen is administered to the patient, and where in said second treatment phase at least one transdermal therapy system containing at least one estrogen and one gestagen is administered to the patient, wherein,

at the start of the first treatment phase, at least one bag containing a transdermal therapy system with at least one estrogen is removed from the multipack and the transdermal therapy system contained therein is applied to the patient's skin, and

at the start of the second treatment phase, at least one bag containing a transdermal therapy system with at least one estrogen and one gestagen is removed for said multipack and the transdermal therapy system containing therein is applied to the patient's skin.

2. A method according to claim 1 wherein the multipack contains a defined number of different transdermal therapy systems in individual bags.

3. A method according to claim 1 wherein said multipack contains about four transdermal therapy systems to be used in the first treatment phase and about four transdermal therapy systems to be used in the second treatment phase.

4. A method according to claim 1 wherein said first treatment phase lasts about 14 days and said second treatment phase lasts about 14 days.

5. A method according to claim 1 wherein the transdermal administration of hormones is used within a hormone replacement therapy.

6. A method according to claim 1 wherein the uppermost bag is removed from the multipack.

7. A method according to claim 1 wherein the bags are removed in the sequence of application of the transdermal therapy systems.

8. A method according to claim 1 wherein the individual bags are provided with printed information indicating the sequence of removal.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2006
From: NEE, HAN H.
To: TARGET TECHNOLOGY COMPANY, LLC
Reel/Frame 017946/0001 →